Skip to main content
. 2022 Apr 21;96(9):e00332-22. doi: 10.1128/jvi.00332-22

FIG 3.

FIG 3

mAbs exhibit changes in NAI and neutralizing activities toward EMVs. (A and B) Heat maps of fold changes in NAI IC50s of each mAb against EMVs (A) or rNA proteins (B). (C) Fold changes in neutralization IC50s of each mAb against EMVs. Darker blue is a higher fold change in the IC50, which indicates stronger escape phenotypes. NAI and neutralization assays were conducted in duplicate.